Tiziana Life Sciences Ltd
TLSA
$1.18
$0.054.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.43M | -15.64M | -12.84M | -12.35M | -11.86M |
| Total Depreciation and Amortization | 234.00K | 192.00K | 150.00K | 137.00K | 124.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.29M | 5.08M | 7.87M | 9.32M | 10.77M |
| Change in Net Operating Assets | 3.06M | -435.00K | -3.93M | -2.24M | -552.00K |
| Cash from Operations | -12.85M | -10.80M | -8.75M | -5.14M | -1.53M |
| Capital Expenditure | -21.00K | -16.00K | -11.00K | -15.00K | -19.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.06M | 2.98M | 2.89M | 1.44M | -- |
| Cash from Investing | 3.04M | 2.96M | 2.88M | 1.43M | -19.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -196.00K | -158.00K | -120.00K | -130.50K | -141.00K |
| Issuance of Common Stock | 10.15M | 11.10M | 12.05M | 8.35M | 4.65M |
| Repurchase of Common Stock | -- | -26.00K | -52.00K | -52.00K | -52.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 48.00K | 24.00K | -- | -- | -- |
| Cash from Financing | 10.01M | 10.94M | 11.88M | 8.17M | 4.45M |
| Foreign Exchange rate Adjustments | 84.00K | 98.50K | 113.00K | -127.00K | -367.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 286.00K | 3.20M | 6.12M | 4.33M | 2.54M |